تخطَّ إلى المحتوى
دليل الأدوية المصري
تابع آخر تحديثات الأسعار على واتساب

سعر روفينديوم 60مجم 20 قرص 2023

Rofendium 60 mg 20 tabs

معلومات الدواء

التفاصيل الكاملة
دواعي الاستعمالUses
  • Directory use: analgesic and anti-inflammatory for rheumatoid arthritis joints and bone pain in osteoporosis.
  • Relief of inflammation and pain in rheumatoid arthritis, osteoarthritis, low back pain, periarthritis of the shoulder, shoulder-arm-neck syndrome and toothache; postoperative, post-traumatic and post-extraction pain; antipyresis and analgesia in acute upper respiratory tract inflammation.Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Directory use: analgesic and anti-inflammatory for rheumatoid arthritis joints and bone pain in osteoporosis.
  • Relief of inflammation and pain in rheumatoid arthritis, osteoarthritis, low back pain, periarthritis of the shoulder, shoulder-arm-neck syndrome and toothache; postoperative, post-traumatic and post-extraction pain; antipyresis and analgesia in acute upper respiratory tract inflammation.Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
الآثار الجانبيةSide effects
  • Adverse reactions in 3.03% of 13,486 patients, mainly GI symptoms (stomach discomfort, abdominal pain, nausea/vomiting, anorexia: 2.25%), oedema (0.59%), rash/urticaria (0.21%), sleepiness (0.10%).نشرة دولية لتركيبة مكافئة · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Clinically significant (incidence unknown): shock/anaphylactoid reactions, haemolytic anaemia, leukopenia, thrombocytopenia, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute renal failure, congestive heart failure, interstitial pneumonia, hepatic dysfunction, asthmatic attack, aseptic meningitis.نشرة دولية لتركيبة مكافئة · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Adverse reactions in 3.03% of 13,486 patients, mainly GI symptoms (stomach discomfort, abdominal pain, nausea/vomiting, anorexia: 2.25%), oedema (0.59%), rash/urticaria (0.21%), sleepiness (0.10%).International label, equivalent formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Clinically significant (incidence unknown): shock/anaphylactoid reactions, haemolytic anaemia, leukopenia, thrombocytopenia, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute renal failure, congestive heart failure, interstitial pneumonia, hepatic dysfunction, asthmatic attack, aseptic meningitis.International label, equivalent formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
موانع الاستعمالContraindications
  • Peptic ulcer.نشرة دولية لتركيبة مكافئة · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Severe blood disorders, severe hepatic disorders, severe renal impairment or severe cardiac failure.نشرة دولية لتركيبة مكافئة · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • History of hypersensitivity to any ingredient.نشرة دولية لتركيبة مكافئة · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
عرض الكل (5)
  • Peptic ulcer.International label, equivalent formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Severe blood disorders, severe hepatic disorders, severe renal impairment or severe cardiac failure.International label, equivalent formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • History of hypersensitivity to any ingredient.International label, equivalent formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
Show all (5)
تحذيرات واحتياطاتWarnings & precautions
  • Use with caution in history of peptic ulcer, blood, hepatic or renal disorders, cardiac dysfunction, bronchial asthma, ulcerative colitis, Crohn's disease and the elderly.نشرة دولية لتركيبة مكافئة · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Symptomatic, not causal, treatment; in chronic use perform periodic urinalysis, blood tests and liver function tests; may mask signs of infection; avoid concomitant other anti-inflammatory analgesics.نشرة دولية لتركيبة مكافئة · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Use with caution in history of peptic ulcer, blood, hepatic or renal disorders, cardiac dysfunction, bronchial asthma, ulcerative colitis, Crohn's disease and the elderly.International label, equivalent formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Symptomatic, not causal, treatment; in chronic use perform periodic urinalysis, blood tests and liver function tests; may mask signs of infection; avoid concomitant other anti-inflammatory analgesics.International label, equivalent formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
التداخلات الدوائيةDrug interactions
  • Coumarin anticoagulants (e.g. warfarin)Anticoagulant effect may be enhanced; reduce dose as necessary.Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Sulfonylureas (e.g. tolbutamide)Hypoglycaemic effect may be enhanced.Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • New quinolones (e.g. enoxacin)Convulsant effect may be enhanced.Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
عرض الكل (6)
  • Coumarin anticoagulants (e.g. warfarin)Anticoagulant effect may be enhanced; reduce dose as necessary.Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Sulfonylureas (e.g. tolbutamide)Hypoglycaemic effect may be enhanced.Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • New quinolones (e.g. enoxacin)Convulsant effect may be enhanced.Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
Show all (6)
الحمل والرضاعةPregnancy & breastfeeding
  • Use in women who are or may be pregnant only if the expected benefit outweighs the risk; safety not established.نشرة دولية لتركيبة مكافئة · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Avoid use in nursing women; if necessary, breastfeeding should be discontinued (excreted in rat milk).نشرة دولية لتركيبة مكافئة · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Use in women who are or may be pregnant only if the expected benefit outweighs the risk; safety not established.International label, equivalent formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)
  • Avoid use in nursing women; if necessary, breastfeeding should be discontinued (excreted in rat milk).International label, equivalent formulation · Saja Pharma (Saudi Arabian Japanese Pharmaceutical Co.)

المثائل (3)

كل المثائل والبدائل

نفس المادة الفعالة والتركيز. اسأل الصيدلي قبل الاستبدال.

مثائل روفينديوم 60مجم 20 قرص بنفس المادة الفعالة والتركيز، مرتبة من الأرخص
روكسونين 60مجم 20 قرصRoxonin 60 mg 20 film-coated tabletsGenuine Pharma · أقراص مغلفة (وفق الدليل المصري) · 60 mgالأرخصالسعر25.2ج.م1.26ج.م للوحدةالفرق عن الأصليأرخص 5.3ج.م (17.4%)
روكسوجيسك 60مجم 20 قرصRoxogesic 60mg 20 tabTag Pharma · قرص · 60 mgالسعر76ج.م3.8ج.م للوحدةالفرق عن الأصليأغلى 45.5ج.م (149.2%)
لوجاين 60مجم 20 كبسولةLoujain 60mg 20 caps.Hochster Pharmaceutical Industries · كبسولة · 60 mgشكل مختلفالسعر20ج.م1ج.م للوحدةالفرق عن الأصليأرخص 10.5ج.م (34.4%)

أدوية ذات صلة

منتجات أخرى من P & C Labs

من فئة مضاد التهاب غير ستيرويدي

المصادر

تعليقات

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.

أضف تعليقًا

0/60

لا يُنشر أبدًا؛ للتواصل فقط إن لزم.

0/1000

من 20 إلى 1000 حرف. بدون روابط.

التعليقات للمعلومات العامة ولا تُعد نصيحة طبية. لا تذكر بيانات شخصية.